Skip to main content
SPRUCE BIOSCIENCES, INC. logo

SPRUCE BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · SPRB ISIN · US85209E1091 US Professional, scientific and technical activities
Filings indexed 323 across all filing types
Latest filing 2025-11-24 Major Shareholding Noti…
Country US United States of America
Listing US SPRB

About SPRUCE BIOSCIENCES, INC.

https://sprucebio.com/

Spruce Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for serious, underserved neurological disorders. The company's mission is to advance targeted, first-in-class treatments to address significant unmet medical needs. Its lead investigational therapy, TA-ERT, is being advanced for conditions such as MPS IIIB (Sanfilippo Syndrome Type B), a rare and progressive neurological disease. Guided by a patient-centric approach, Spruce Biosciences aims to develop transformative therapies that offer meaningful outcomes beyond conventional approaches.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-24 English
10-Q
Interim / Quarterly Report 9M 2025
2025-11-10 English
8-K
Regulatory Filings
2025-11-10 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-07 English
S-3
Registration Form
2025-10-29 English
S-3
Registration Form
2025-10-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.